• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    4/25/25 8:19:44 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance
    Get the next $OPY alert in real time by email
    opy-20250425
    0000791963false00007919632024-10-252024-10-25

    As filed with the Securities and Exchange Commission on April 25, 2025
    ___________________________________________________
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): April 25, 2025

    OPPENHEIMER HOLDINGS INC.
    (Exact name of registrant as specified in its charter)

    Commission File Number 1-12043
    Delaware 98-0080034
    (State or other jurisdiction of (I.R.S. Employer
    incorporation or organization) Identification No.)
    85 Broad Street
    New York, New York 10004
    (Address of principal executive offices) (Zip Code)
    (212) 668-8000
    (Registrant's telephone number, including area code)

    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CRF 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Class A non-voting common stockOPYThe New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    SECTION 2 – FINANCIAL INFORMATION

    ITEM 2.02. Results of Operations and Financial Condition.

    (a)On April 25, 2025, Oppenheimer Holdings Inc. (the “Company”) issued a press release announcing its first quarter 2025 earnings. A copy of the April 25, 2025 press release is furnished as Exhibit 99.1 to this Report and is incorporated herein by reference.

    The information contained in this Item 2.02 and the related exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information or such exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth in this Item 2.02 or any exhibit related to this Item 2.02 on this Form 8-K shall not be deemed an admission as to the materiality of any information in the referenced items.


    SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

    ITEM 9.01. Financial Statements and Exhibits.

    (d)Exhibits:

    The following exhibit is furnished (not filed) with this Current Report on Form 8-K:

    99.1 Oppenheimer Holdings Inc.'s Press Release dated April 25, 2025
    2




    SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


    Oppenheimer Holdings Inc.
    Date: April 25, 2025

    By: /s/ Brad M. Watkins
    ---------------------------------
    Brad M. Watkins
    Chief Financial Officer
    (Duly Authorized Officer)

    3




    EXHIBIT INDEX

    Exhibit NumberDescription
    99.1
    Oppenheimer Holdings Inc.'s Press Release dated April 25, 2025
    4
    Get the next $OPY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OPY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OPY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    David Wright Joins Oppenheimer As Managing Director in the Pacific Northwest

    Mark Trafford Promoted to Serve Alongside Wright to Lead the Region NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE:OPY), today announced the appointment of David Wright as Managing Director and Co-Regional Manager for the Pacific Northwest. Meanwhile, Mark Trafford has been promoted to serve alongside Wright to co-lead the region. Both report to Ed Harrington, Executive Vice President and Head of Private Client Division at Oppenheimer. "We are thrilled to welcome David to Oppenheimer," said Harrington. "He brings the right energy, deep market knowledge and leaders

    8/5/25 9:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. Reports Second Quarter 2025 Earnings

    NEW YORK, Aug. 1, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the second quarter of 2025, compared with net income of $10.3 million or $0.99 basic earnings per share for the second quarter of 2024. Revenue for the second quarter of 2025 was $373.2 million, an increase of 12.9%, compared to revenue of $330.6 million for the second quarter of 2024. Robert S. Lowenthal, President and CEO commented, "The Firm's improved operating results for the quarter showcase the strength of our businesses and the maturing of investments in experienced team members over the past several yea

    8/1/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Appoints Jon Hudson As Managing Director and Co-head of Healthcare Services Investment Banking

    Veteran Dealmaker Brings More Than 25 Years of Healthcare Industry Experience NEW YORK, July 14, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), announced today the appointment of Jon Hudson as Managing Director and Co-Head of its Healthcare Services Investment Banking team. Hudson will report to Michael Margolis, R.Ph., Head of Oppenheimer's Healthcare Investment Banking Group, and work out of the firm's Miami and Atlanta offices. "On behalf of the entire Healthcare Investment Banking group, I'm pleased to welcome Jon to Oppenheimer," said Margolis. "Jon is a highly respected advi

    7/14/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Secretary Mcnamara Dennis P sold $147,620 worth of Class A non-voting common stock (2,000 units at $73.81), decreasing direct ownership by 8% to 21,766 units (SEC Form 4)

    4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    8/6/25 11:16:49 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Director Friedman Paul M sold $443,199 worth of Class A non-voting common stock (7,000 units at $63.31) (SEC Form 4)

    4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    6/10/25 5:27:25 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Director Friedman Paul M sold $189,320 worth of Class A non-voting common stock (3,000 units at $63.11) (SEC Form 4)

    4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    6/9/25 4:03:38 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Leadership Updates

    Live Leadership Updates

    View All

    David Wright Joins Oppenheimer As Managing Director in the Pacific Northwest

    Mark Trafford Promoted to Serve Alongside Wright to Lead the Region NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE:OPY), today announced the appointment of David Wright as Managing Director and Co-Regional Manager for the Pacific Northwest. Meanwhile, Mark Trafford has been promoted to serve alongside Wright to co-lead the region. Both report to Ed Harrington, Executive Vice President and Head of Private Client Division at Oppenheimer. "We are thrilled to welcome David to Oppenheimer," said Harrington. "He brings the right energy, deep market knowledge and leaders

    8/5/25 9:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Appoints Jon Hudson As Managing Director and Co-head of Healthcare Services Investment Banking

    Veteran Dealmaker Brings More Than 25 Years of Healthcare Industry Experience NEW YORK, July 14, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), announced today the appointment of Jon Hudson as Managing Director and Co-Head of its Healthcare Services Investment Banking team. Hudson will report to Michael Margolis, R.Ph., Head of Oppenheimer's Healthcare Investment Banking Group, and work out of the firm's Miami and Atlanta offices. "On behalf of the entire Healthcare Investment Banking group, I'm pleased to welcome Jon to Oppenheimer," said Margolis. "Jon is a highly respected advi

    7/14/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Adds to Technology Banking Group with the Hire of Ranjot Singh as Managing Director

    NEW YORK, March 25, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. — a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY) — announced today that Ranjot Singh has joined the Firm as a Managing Director in its Technology Investment Banking Group. He will be based in Oppenheimer's New York office and report to Robin Graham, Head of Technology Investment Banking. "Ranjot's M&A expertise with large and highly technical transactions across the Technology sector is the perfect addition to our growing advisory practice," Graham said. "He has advised both public and private companies at the highest levels and will complement the deep industry expertise of our most

    3/25/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    SEC Filings

    View All

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    8/4/25 9:31:48 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    8/1/25 8:18:31 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-Q filed by Oppenheimer Holdings Inc.

    10-Q - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    8/1/25 8:16:36 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oppenheimer Holdings, Inc. (Amendment)

    SC 13G/A - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)

    9/23/21 3:31:42 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G filed by Oppenheimer Holdings, Inc.

    SC 13G - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)

    6/25/21 2:44:05 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Financials

    Live finance-specific insights

    View All

    Oppenheimer Holdings Inc. Reports Second Quarter 2025 Earnings

    NEW YORK, Aug. 1, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the second quarter of 2025, compared with net income of $10.3 million or $0.99 basic earnings per share for the second quarter of 2024. Revenue for the second quarter of 2025 was $373.2 million, an increase of 12.9%, compared to revenue of $330.6 million for the second quarter of 2024. Robert S. Lowenthal, President and CEO commented, "The Firm's improved operating results for the quarter showcase the strength of our businesses and the maturing of investments in experienced team members over the past several yea

    8/1/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. Reports First Quarter 2025 Earnings

    NEW YORK, April 25, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $30.7 million or $2.93 basic earnings per share for the first quarter of 2025, compared with net income of $26.1 million or $2.50 basic earnings per share for the first quarter of 2024. Revenue for the first quarter of 2025 was $367.8 million, an increase of 4.2%, compared to revenue of $353.1 million for the first quarter of 2024. Albert G. Lowenthal, Chairman and CEO commented, "The Firm's solid performance for the quarter underscores the ability of our diversified businesses to deliver profitable operating results in increasingly uncertain macroeconomic cond

    4/25/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2024 Earnings

    NEW YORK, Jan. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024 compared with net income of $11.1 million or $1.07 basic earnings per share for the fourth quarter of 2023. Fourth quarter and full year 2024 results were significantly impacted by higher pre-tax compensation expenses for liability-based awards totaling $20.5 million and $32.6 million, respectively, attributable to an increase in OPY Class A share price. Revenue for the fourth quarter of 2024 was $375.4 million compared to revenue of $308.3 million for the fourth quarter of 2023, an in

    1/31/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance